4.1 Article

COVID-19-Induced Sporadic Inclusion Body Myositis

期刊

CUREUS JOURNAL OF MEDICAL SCIENCE
卷 14, 期 10, 页码 -

出版社

CUREUS INC
DOI: 10.7759/cureus.30808

关键词

infectious myositis; sporadic inclusion body myositis; viral myositis; inclusion body myositis; covid 19

向作者/读者索取更多资源

Sporadic inclusion body myositis (sIBM) is a rare autoimmune disease characterized by progressive weakness and muscular atrophy in the extremities. Although the exact pathophysiology is unclear, some studies suggest that cytotoxic T cells (CD8+) are involved, leading to an autoimmune response. This case report highlights a rare implication of COVID-19, as it was found to be associated with the development of sIBM in a patient with chronic myalgias.
Sporadic inclusion body myositis (sIBM) is an autoimmune condition that is characterized by progressive weakness and muscular atrophy in the extremities. The pathophysiology is not exactly clear; however, some studies have postulated an involvement of cytotoxic T cells (CD8+), causing an autoimmune response. While the implications of COVID-19 infection are an evolving topic, myositis has been previously implicated in other viral etiologies. We discuss a case of sIBM secondary to COVID-19 in a patient with chronic myalgias bringing to light a rare implication of COVID-19 to educate the medical community.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据